State Street Corp Pliant Therapeutics, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,279,694 shares of PLRX stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,279,694

Previous 1,385,236 7.62%

Holding current value

$1.61 Million

Previous $18.2 Million 90.53%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.35 - $13.53 $142,481 - $1.43 Million	-105,542 Reduced 7.62%	1,279,694 $1.73 Million
Q4 2024 Feb 14, 2025	SELL	$10.55 - $15.7 $184,561 - $274,655	-17,494 Reduced 1.25%	1,385,236 $18.2 Million
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $279,937 - $381,853	26,610 Added 1.93%	1,402,730 $15.7 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $606,794 - $895,280	57,353 Added 4.35%	1,376,120 $14.8 Million
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $233,465 - $323,450	-16,511 Reduced 1.24%	1,318,767 $19.6 Million
Q4 2023 Feb 14, 2024	BUY	$12.85 - $19.15 $224,579 - $334,684	17,477 Added 1.33%	1,335,278 $24.2 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $1.65 Million - $2.27 Million	112,861 Added 9.37%	1,317,801 $22.9 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $16.6 Million - $28 Million	914,839 Added 315.35%	1,204,940 $21.8 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $548,339 - $1.06 Million	29,276 Added 11.22%	290,101 $7.72 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $803,148 - $1.2 Million	47,244 Added 22.12%	260,825 $5.04 Million
Q3 2022 Nov 15, 2022	BUY	$7.67 - $24.23 $982,626 - $3.1 Million	128,113 Added 149.9%	213,581 $4.46 Million
Q2 2022 Aug 15, 2022	SELL	$4.11 - $8.75 $1.49 Million - $3.16 Million	-361,528 Reduced 80.88%	85,468 $685,000
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $16,592 - $33,374	2,367 Added 0.53%	446,996 $3.13 Million
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $326,701 - $486,190	26,626 Added 6.37%	444,629 $6 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $543,757 - $956,195	32,995 Added 8.57%	418,003 $7.06 Million
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $133,489 - $179,366	4,759 Added 1.25%	385,008 $11.2 Million
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $4.89 Million - $8.02 Million	199,258 Added 110.09%	380,249 $15 Million
Q4 2020 Feb 16, 2021	BUY	$19.89 - $32.99 $1.21 Million - $2.01 Million	60,784 Added 50.57%	180,991 $4.11 Million
Q3 2020 Nov 10, 2020	BUY	$21.54 - $29.53 $2.59 Million - $3.55 Million	120,207 New	120,207 $2.72 Million

Others Institutions Holding PLRX

# of Institutions

154

Shares Held

62.2M

Call Options Held

279K

Put Options Held

7.1K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $61.3M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Pliant Therapeutics, Inc. Transaction History